Alkem Labs shares fall 2% as US FDA issues warning letter to its Daman manufacturing facility
Alkem Labs stated that it continues to manufacture and supply approved products from the said facility to the US market, adding that there is no material impact on current operations, financial, or other activities of the company.

What's Your Reaction?









